News
Sarepta Will Resume Gene Therapy Shipments
Digest more
Elevidys is an adeno-associated virus vector-based gene therapy that uses Sarepta’s AAVrh74 Platform Technology to treat DMD, ...
FDA probes Elevidys after an 8-year-old's death in Brazil; Sarepta and Roche say the death was unrelated to gene therapy ...
Sarepta Therapeutics now trades at book value with strong cash and cost-cutting plans, while ELEVIDYS may regain broader use.
Sarepta shares gained even though the U.S. Food and Drug Administration said late Friday that it was probing the death of an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback